Intravenous miconazole in the treatment of chronic esophageal candidiasis.

[1]  D. Stevens,et al.  Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. , 1976, The American journal of medicine.

[2]  H. Wüst,et al.  Erfolgreiche Behandlung der Hefesepsis mit Miconazol , 1974 .

[3]  C. Culbertson.  MONISTAT: a new fungicide for treatment of vulvovaginal candidiasis. , 1974, American journal of obstetrics and gynecology.

[4]  E. Goldstein,et al.  Miconazole therapy for coccidioidomycosis. , 1974, JAMA.

[5]  M. Borgers,et al.  The ultrastructure of Candida albicans after in vitro treatment with miconazole. , 1974, Sabouraudia.

[6]  S. Mandy,et al.  Miconazole treatment for severe dermatophytoses. , 1974, JAMA.

[7]  Davis Je,et al.  Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis. , 1974 .

[8]  L. Eggers,et al.  [Therapy of systemic candidiasis using miconazol]. , 1974, Die Medizinische Welt.

[9]  H. Bossche.  Biochemical effects of miconazole on fungi. I. Effects on the uptake and or utilization of purines, pyrimidines, nucleosides, amino acids and glucose by Candida albicans. , 1974 .

[10]  J. V. van Cutsem,et al.  Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. , 1972, Chemotherapy.

[11]  D. Sheft,et al.  Esophageal moniliasis. The spectrum of the disease. , 1970, JAMA.

[12]  W. Butler,et al.  Successful treatment of chronic esophageal moniliasis with a viscous suspension of nystatin. , 1969, Gastroenterology.

[13]  A. Stenderup,et al.  OESOPHAGEAL MONILIASIS IN MALIGNANT NEOPLASTIC DISEASE. , 2009, Acta Medica Scandinavica.